Insider Transactions Reported by 36 Insiders of JOHNSON & JOHNSON

Symbol
JNJ on NYSE
Location
New Brunswick, NJ

Insiders trading volume in the past year

JOHNSON & JOHNSON executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alex Gorsky Director $132,153,735 17 Jan 2023
Joaquin Duato CEO and Chairman of the Board, Director $88,349,558 -$44,671,548 -34% 13 Feb 2026
Jennifer L. Taubert EVP, WWC. Innovative Medicine $48,204,011 -$10,040,883 -17% 13 Feb 2026
Michael H. Ullmann Exec VP, General Counsel $31,906,242 14 Feb 2022
Kathryn E. Wengel EVP, Chief TO and Risk Officer $28,204,107 13 Feb 2026
Peter Fasolo Exec VP, Chief HR Officer $21,756,253 15 Feb 2024
Joseph J. Wolk Exec VP, CFO $20,446,898 -$24,743,398 -55% 13 Feb 2026
Thibaut Mongon Exec VP, WW Chair, Cons Health $15,974,106 13 Feb 2023
Mathai Mammen EVP, Pharm, R&D $10,751,687 14 Feb 2022
John C. Reed EVP, Innovative Medicine, R&D $10,315,169 -$20,420,856 -66% 15 Feb 2026
James D. Swanson Evp, Cio $10,018,736 -$15,109,759 -60% 13 Feb 2026
William Hait EVP, Chief EI and Med Officer $9,578,502 15 Feb 2024
Ashley McEvoy EVP, WW Chair, MedTech $9,484,760 23 Aug 2023
Vanessa Broadhurst EVP, Global Corp Affairs $8,400,124 -$1,508,288 -15% 13 Feb 2026
Timothy Schmid EVP, WW Chair, MedTech $6,911,910 -$5,852,268 -46% 20 Feb 2026
Elizabeth Forminard EVP, Chief Legal Officer $6,235,591 13 Feb 2026
Robert J. Decker VP Corporate Controller $6,221,796 -$1,010,070 -14% 27 Feb 2026
Kristen Mulholland EVP, Chief HR Officer $5,096,972 13 Feb 2026
A. Eugene Washington Director $4,542,828 07 Mar 2023
Ronald A. Williams Director $4,082,264 15 Feb 2022
Charles O Prince Director $3,947,229 15 Feb 2022
Anne M. Mulcahy Director $3,481,675 25 Apr 2024
Mark B. McClellan Director $2,897,429 24 Apr 2025
Marillyn A. Hewson Director $2,860,628 09 Dec 2025
Ian Davis Director $2,815,437 15 Feb 2022
D. Scott Davis Director $2,589,274 25 Apr 2024
Mary C. Beckerle Director $2,212,351 24 Apr 2025
Mark A. Weinberger Director $1,627,636 24 Apr 2025
Jennifer A. Doudna Director $1,310,518 24 Apr 2025
Hubert Joly Director $1,048,226 24 Apr 2025
Eugene A. Woods Director $1,022,336 10 Mar 2026
Nadja West Director $825,991 24 Apr 2025
Darius Adamczyk Director $602,052 25 Apr 2024
Paula A. Johnson Director $481,960 24 Apr 2025
John George Morikis Director $381,070 +$257,688 +209% 26 Nov 2025
Daniel E. Pinto Director $66,948 10 Mar 2026

Recent Insider Transactions by Companies or Individuals for JOHNSON & JOHNSON

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Marillyn A. Hewson JNJ Deferred Share Units Award 1.44% 206 14,513 10 Mar 2026 Direct
Daniel E. Pinto JNJ Deferred Share Units Award 38.8% 129 462 10 Mar 2026 Direct
Eugene A. Woods JNJ Deferred Share Units Award 3.05% 155 5,240 10 Mar 2026 Direct
Robert J. Decker JNJ Common Stock Sale -14.7% $1,010,070 $247.87 -4,075 23,682 27 Feb 2026 Direct
Robert J. Decker JNJ Common Stock Options Exercise 17.2% 4,075 27,757 27 Feb 2026 Direct
Robert J. Decker JNJ Employee Stock Options (Right to Buy) Options Exercise -100% -4,075 0 27 Feb 2026 Direct
Timothy Schmid JNJ Common Stock Sale -4.94% $324,763 $245.66 -1,322 25,447 20 Feb 2026 Direct
Timothy Schmid JNJ Common Stock Sale -45.8% $5,527,506 $244.33 -22,623 26,769 18 Feb 2026 Direct
Timothy Schmid JNJ Common Stock Options Exercise 127.3% 22,623 40,394 18 Feb 2026 Direct
Timothy Schmid JNJ Employee Stock Options (Right to Buy) Options Exercise -100% -22,623 0 18 Feb 2026 Direct
James D. Swanson JNJ Common Stock Sale -44.4% $4,980,447 $242.70 -20,521 25,698 17 Feb 2026 Direct
James D. Swanson JNJ Common Stock Options Exercise 79.8% 20,521 46,219 17 Feb 2026 Direct
James D. Swanson JNJ Employee Stock Options (Right to Buy) Options Exercise -100% -20,521 0 17 Feb 2026 Direct
Joseph J. Wolk JNJ Common Stock Sale -86.5% $21,767,827 $242.80 -89,654 14,000 17 Feb 2026 Direct
Joseph J. Wolk JNJ Common Stock Options Exercise 845.2% 64,693 72,347 17 Feb 2026 Direct
Joseph J. Wolk JNJ Employee Stock Options (Right to Buy) Options Exercise -100% -64,693 0 17 Feb 2026 Direct
John C. Reed JNJ Common Stock Sale -83.5% $13,105,233 $243.00 -53,931 10,658 17 Feb 2026 Direct
John C. Reed JNJ Common Stock Options Exercise 51,648 42,868 17 Feb 2026 Direct
John C. Reed JNJ Employee Stock Options (Right to Buy) Options Exercise -70.4% -51,648 21,721 17 Feb 2026 Direct
Vanessa Broadhurst JNJ Common Stock Sale -21.2% $1,508,288 $243.39 -6,197 23,003 17 Feb 2026 Direct
James D. Swanson JNJ Common Stock Tax liability -2.03% -523 25,298 15 Feb 2026 Direct
James D. Swanson JNJ Common Stock Options Exercise 4.84% 1,201 26,007 15 Feb 2026 Direct
James D. Swanson JNJ Restricted Share Units Award 1,397 1,397 15 Feb 2026 Direct
James D. Swanson JNJ Employee Stock Options (Right to Buy) Award 19,449 19,449 15 Feb 2026 Direct
James D. Swanson JNJ Restricted Share Units Options Exercise -71% -1,201 491 15 Feb 2026 Direct
Kathryn E. Wengel JNJ Common Stock Tax liability -0.55% -635 113,978 15 Feb 2026 Direct
Kathryn E. Wengel JNJ Common Stock Options Exercise 1.09% 1,241 114,613 15 Feb 2026 Direct
Kathryn E. Wengel JNJ Restricted Share Units Award 1,217 1,217 15 Feb 2026 Direct
Kathryn E. Wengel JNJ Employee Stock Options (Right to Buy) Award 16,945 16,945 15 Feb 2026 Direct
Kathryn E. Wengel JNJ Restricted Share Units Options Exercise -67.2% -1,241 606 15 Feb 2026 Direct
Kristen Mulholland JNJ Common Stock Tax liability -2.12% -423 19,506 15 Feb 2026 Direct
Kristen Mulholland JNJ Common Stock Options Exercise 5.21% 994 20,081 15 Feb 2026 Direct
Kristen Mulholland JNJ Restricted Share Units Award 1,459 1,459 15 Feb 2026 Direct
Kristen Mulholland JNJ Employee Stock Options (Right to Buy) Award 20,322 20,322 15 Feb 2026 Direct
Kristen Mulholland JNJ Restricted Share Units Options Exercise -70.4% -994 418 15 Feb 2026 Direct
Joseph J. Wolk JNJ Common Stock Tax liability -4.23% -1,675 37,900 15 Feb 2026 Direct
Joseph J. Wolk JNJ Common Stock Options Exercise 10.7% 3,849 39,778 15 Feb 2026 Direct
Joseph J. Wolk JNJ Restricted Share Units Award 3,863 3,863 15 Feb 2026 Direct
Joseph J. Wolk JNJ Employee Stock Options (Right to Buy) Award 53,793 53,793 15 Feb 2026 Direct
Joseph J. Wolk JNJ Restricted Share Units Options Exercise -66.1% -3,849 1,971 15 Feb 2026 Direct
Robert J. Decker JNJ Common Stock Tax liability -0.8% -189 23,433 15 Feb 2026 Direct
Robert J. Decker JNJ Common Stock Options Exercise 2.96% 683 23,777 15 Feb 2026 Direct
Robert J. Decker JNJ Restricted Share Units Award 700 700 15 Feb 2026 Direct
Robert J. Decker JNJ Employee Stock Options (Right to Buy) Award 4,871 4,871 15 Feb 2026 Direct
Robert J. Decker JNJ Restricted Share Units Options Exercise -66.9% -683 338 15 Feb 2026 Direct
John C. Reed JNJ Common Stock Tax liability -7.28% -913 11,622 15 Feb 2026 Direct
John C. Reed JNJ Common Stock Options Exercise 31.1% 3,196 13,469 15 Feb 2026 Direct
John C. Reed JNJ Restricted Share Units Award 3,546 3,546 15 Feb 2026 Direct
John C. Reed JNJ Employee Stock Options (Right to Buy) Award 49,382 49,382 15 Feb 2026 Direct
John C. Reed JNJ Restricted Share Units Options Exercise -70.3% -3,196 1,349 15 Feb 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.